KRYS
Krystal Biotech, Inc.
Nasdaq Biological Products, (No Diagnostic Substances) Large accelerated filer

Key Financials

Operating Income
$161.3M
↑ 145.5%
Net Income
$204.8M
↑ 129.7%
Revenue
$389.1M
↑ 33.9%
EPS (Diluted)
$6.84
↑ 128.0%
Total Assets
$1.3B
↑ 26.3%
Cash & Equivalents
$496.3M
↑ 43.9%
Shareholders' Equity
$1.2B
↑ 28.9%
Total Liabilities
$114.2M
↑ 4.4%

Recent SEC Filings

Form Type Filed Date Link
ARS 4/3/2026 View on SEC
DEFA14A 4/3/2026 View on SEC
DEF 14A 4/3/2026 View on SEC
SCHEDULE 13G/A 3/27/2026 View on SEC
3 3/6/2026 View on SEC
3 3/6/2026 View on SEC
4 3/6/2026 View on SEC
4 3/6/2026 View on SEC
144 3/4/2026 View on SEC
144 3/4/2026 View on SEC

Company Information

Field Value
Ticker KRYS
Company Name Krystal Biotech, Inc.
CIK 1711279
Sector Biological Products, (No Diagnostic Substances)
Industry Large accelerated filer
Exchange Nasdaq
SIC Code 2836
SIC Description Biological Products, (No Diagnostic Substances)
Entity Type operating
Fiscal Year End 1231
Phone (412) 586-5830